Entrepreneur-friendly, early stage investment company that is focused on the tech and energy sectors. The WOC objective is investing in smart ideas and visionary thinking through positive relationships, mutual respect, and shared passion.
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 21
| Date | Name | Website | Total Raised | Location |
| - | TurnCare | turncare.com | - | United Sta... |
| - | North Coas... | northcoastgastransmission.com | - | United Sta... |
| - | Happiest B... | happiestbaby.com | $23M | United Sta... |
| - | generationpipeline.com | - | - | |
| - | PharmaCan ... | thecronosgroup.com | - | Canada, On... |
| - | TABLOGIX | tablogix.ru | - | - |
| - | Vigilant B... | vigilantbiosciences.com | $16M | United Sta... |
| - | Velano Vas... | velanovascular.com | $60.5M | United Sta... |
| - | DotAlign, ... | dotalign.com | - | United Sta... |
| - | Beboe | beboe.com | - | - |
Show more
Mentions in press and media 2
| Date | Title | Description |
| 17.12.2019 | Velano Vascular reels in $25M to keep building blood-draw business | “We refer to it as the one-stick hospitalization,” Eric Stone, Velano Vascular’s CEO, said in a phone interview. “Our aim, and I’ve been very open about this, is to make PIVO the standard of care around the world,” he said. More than a bill... |
| - | Velano Vascular reels in $25M to keep building blood-draw business | Velano Vascular has closed on $25 million in funding that will help the company advance its goal of transforming how blood is drawn from hospital patients. The company’s chief product is called the PIVO. The FDA-approved device allows provi... |